These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7276648)

  • 1. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
    Hando T; Kodama S; Obata N; Goto A; Takeuchi S; Aoki S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A result of mass-screening for uterine cervical cancer in Hyogo prefecture (author's transl)].
    Hasegawa K; Miyazaki Y; Kitaura Y; Ohtsu F; Takeuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2097-104. PubMed ID: 7338662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate frequency of mass-screening for uterine cervical cancer.
    Iwanari O
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1799-805. PubMed ID: 3429977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of mass screening for cervical cancer in Shiga Prefecture].
    Ishiguro T; Yoshida Y; Tenzaki T; Tanaka B
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):655-60. PubMed ID: 6864024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in awareness of cervical cancer patients after medical treatments and the correlation of cervical screening situation and clinical stage at consultation].
    Wang CF; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):361-3. PubMed ID: 22883525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the appropriated interval of mass screening for cervical cancer].
    Kusanagi T; Kudo R; Ito E; Sagae S; Hori Y; Tamura H; Hayakawa O; Fujimura Y; Hashimoto M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun; 35(6):782-6. PubMed ID: 6875333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
    Makino H; Sato S; Yajima A; Fukao A
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal frequency of screening for cervical cancer: a Toronto case-control study.
    Clarke EA; Hilditch S; Anderson TW
    IARC Sci Publ; 1986; (76):125-31. PubMed ID: 3570399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effectiveness of cervical cytology screening for cervical cancer (author's transl)].
    Soost HJ; Bockmühl B; Zock H
    Dtsch Med Wochenschr; 1979 Sep; 104(38):1331-5. PubMed ID: 477559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of cervical neoplasia.
    La Vecchia C
    Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.